Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Contraception|October 23, 2017
Pregnancy outcomes associated with extended use of the 52-mg 20 μg/day levonorgestrel-releasing intrauterine system beyond 60 months: A chart review of 776 women in BrazilLuis Bahamondes, Arlete Fernandes, M Valeria Bahamondes, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|June 14, 2014
Exploratory study of the effect of lifestyle counselling on bone mineral density and body composition in users of the contraceptive depot-medroxyprogesterone acetateWaleska Modesto, M Valeria Bahamondes, Priscila Silva dos Santos, et al.
American Journal of Dentistry|June 4, 2013
Dentin hypersensitivity after teeth bleaching with in-office systems. Randomized clinical trialJavier Martin, Eduardo Fernandez, Valeria Bahamondes, et al.
Contraception|June 9, 2009
Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine systemMaria M Hidalgo, Creusa Hidalgo-Regina, M Valeria Bahamondes, et al.
Contraception|March 20, 2013
Pain at insertion of the levonorgestrel-releasing intrauterine system in nulligravida and parous women with and without cesarean sectionAna Raquel Gouvea Santos, M Valeria Bahamondes, M Margarete Hidalgo, et al.
Contraception|October 25, 2011
A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetateAlexandre S Viola, Sara Castro, M Valeria Bahamondes, et al.
Contraception|July 16, 2011
Long-term assessment of forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetateAlexandre S Viola, Sara Castro, Nadia M Marchi, et al.
Contraception|May 18, 2010
Length of the endometrial cavity as measured by uterine sounding and ultrasonography in women of different paritiesRenata Canteiro, M Valeria Bahamondes, Arlete dos Santos Fernandes, et al.
Archives of Gynecology and Obstetrics|April 4, 2019
Disease activity and thromboembolic events in women with systemic lupus erythematosus with and without anti-phospholipid syndrome: users of the 52-mg levonorgestrel-releasing intrauterine systemRafaella C Rebelo, Estephania Pignaton, M Valeria Bahamondes, et al.
Revista Da Associacao Medica Brasileira (1992)|April 20, 2006
[Weight variation in users of the levonorgestrel-releasing intrauterine system, of the copper IUD and of medroxyprogesterone acetate in Brazil]Daniela Angerame Yela, Ilza Maria Urbano Monteiro, Luis Guillermo Bahamondes, et al.
Pageof 4